Boston Scientific
(NYSE) BSX
Boston Scientific Financials at a Glance
Market Cap
$102.64B
Revenue (TTM)
$20.07B
Net Income (TTM)
$2.89B
EPS (TTM)
$1.94
P/E Ratio
35.67
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$69.21
Volume
450,661
Open
$70.23
Price
$69.21
Volume
450,661
Open
$70.23
Previous Close
$69.21
Daily Range
$68.86 - $70.23
52-Week Range
$67.56 - $109.50
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$69.21
Volume
450,661
Open
$70.23
Previous Close
$69.21
Daily Range
$68.86 - $70.23
52-Week Range
$67.56 - $109.50
BSX News
BSX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Boston Scientific
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
59,000
CEO
Michael F. Mahoney, MBA
Website
www.bostonscientific.comHeadquarters
Marlborough, MA 01752-1234, US
BSX Financials
Key Financial Metrics (TTM)
Gross Margin
69%
Operating Margin
20%
Net Income Margin
14%
Return on Equity
13%
Return on Capital
10%
Return on Assets
7%
Earnings Yield
2.80%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$102.64B
Shares Outstanding
1.48B
Volume
450.66K
Short Interest
0.00%
Avg. Volume
14.76M
Financials (TTM)
Gross Profit
$13.85B
Operating Income
$3.97B
EBITDA
$3.73B
Operating Cash Flow
$4.53B
Capital Expenditure
$876.00M
Free Cash Flow
$3.66B
Cash & ST Invst.
$2.04B
Total Debt
$12.42B
Boston Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.29B
+15.9%
Gross Profit
$3.94B
+47.4%
Gross Margin
74.48%
N/A
Market Cap
$102.64B
N/A
Market Cap/Employee
$1.94M
N/A
Employees
53,000
N/A
Net Income
$668.00M
+18.0%
EBITDA
$956.00M
-10.7%
Quarterly Fundamentals
Net Cash
$10.37B
+3.4%
Accounts Receivable
$2.93B
+14.4%
Inventory
$2.94B
+4.8%
Long Term Debt
$12.03B
+28.4%
Short Term Debt
$389.00M
-78.1%
Return on Assets
6.62%
N/A
Return on Invested Capital
10.39%
N/A
Free Cash Flow
$1.01B
-12.9%
Operating Cash Flow
$1.36B
-6.3%